Does STXS pay dividends?

Stereotaxis Inc (STXS) does not currently pay a regular dividend.

What is STXS's market cap?

Stereotaxis Inc (STXS) has a market capitalization of $144.29M with a current stock price of $1.45.

Stereotaxis Inc (STXS)

Official site

HEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • AMEX

$1.45

+0.00 (+0.00%)

Market Cap: $144.29M

Last updated: Sep 01, 2026 at 5:00 PM ET

Earnings

Performance (10Y)

Beat Rate

54%(14/26)

Avg Surprise

-11.18%

Upcoming Estimates

Period ending Sep 30, 2026

EPS Consensus$-0.05

Range$-0.06 - $-0.04

3 analysts

EPS RevisionsNo revisions (7d)

30d

EPS Estimate Drift

90d ago$0.00+100.0%

60d ago$-0.05+0.0%

30d ago$-0.05+0.0%

7d ago$-0.05+0.0%

Current$-0.05

Revenue Consensus

$11M

Range$11M - $12M

4 analysts

Period ending Dec 31, 2026

EPS Consensus$-0.05

Range$-0.09 - $-0.03

3 analysts

Revenue Consensus

$12M

Range$10M - $12M

4 analysts

Period	Reported	Est.	Range	Surprise	B/M	Analysts	Revisions	YoY
Dec 31, 2026Dec 26EST	-	$-0.05	$-0.09 - $-0.03	-	-	3	-	-
Sep 30, 2026Sep 26EST	-	$-0.05	$-0.06 - $-0.04	-	-	3	0 1 30d	-
Jun 30, 2026Jun 26 Reported Aug 11, 2026Reported Aug 11	$-0.05	$-0.03	$-0.06 - $-0.03	-66.67%	Miss	3	1 0 30d	+0.0%
Mar 31, 2026Mar 26 Reported May 12, 2026Reported May 12	$-0.06	$-0.06	$-0.06 - $-0.04	-10.05%	Miss	3	1 0 30d	+10.9%
Dec 31, 2025Dec 25 Reported Mar 9, 2026Reported Mar 9	$-0.06	$-0.06	$-0.07 - $-0.06	+0.00%	Beat	4	0 2 30d	+33.3%
Sep 30, 2025Sep 25 Reported Nov 11, 2025Reported Nov 11	$-0.07	$-0.06	$-0.07 - $-0.05	-16.67%	Miss	4	No revisions (30d)	+12.5%
Jun 30, 2025Jun 25 Reported Aug 7, 2025Reported Aug 7	$-0.05	$-0.07	$-0.08 - $-0.05	+28.57%	Beat	4	1 0 30d	+28.6%
Mar 31, 2025Mar 25 Reported May 12, 2025Reported May 12	$-0.07	$-0.07	$-0.09 - $-0.06	+0.00%	Beat	4	0 3 30d	-16.7%
Dec 31, 2024Dec 24 Reported Mar 3, 2025Reported Mar 3	$-0.09	$-0.07	$-0.08 - $-0.04	-38.46%	Miss	4	0 2 30d	-28.6%
Sep 30, 2024Sep 24 Reported Nov 11, 2024Reported Nov 11	$-0.08	$-0.05	$-0.07 - $-0.03	-60.00%	Miss	4	No revisions (30d)	-14.3%
Jun 30, 2024Jun 24 Reported Aug 12, 2024Reported Aug 12	$-0.07	$-0.05	$-0.08 - $-0.04	-40.00%	Miss	4	No revisions (30d)	+0.0%
Mar 31, 2024Mar 24 Reported May 13, 2024Reported May 13	$-0.06	$-0.06	$-0.07 - $-0.06	+0.00%	Beat	5	No revisions (30d)	+14.3%
Dec 31, 2023Dec 23 Reported Mar 4, 2024Reported Mar 4	$-0.07	$-0.07	$-0.07 - $-0.06	+0.00%	Beat	5	No revisions (30d)	-16.7%
Sep 30, 2023Sep 23 Reported Nov 9, 2023Reported Nov 9	$-0.07	$-0.06	$-0.07 - $-0.05	-16.67%	Miss	5	No revisions (30d)	+0.0%
Jun 30, 2023Jun 23 Reported Aug 10, 2023Reported Aug 10	$-0.07	$-0.07	$-0.09 - $-0.05	+0.00%	Beat	5	No revisions (30d)	+0.0%
Mar 31, 2023Mar 23 Reported May 9, 2023Reported May 9	$-0.07	$-0.06	$-0.07 - $-0.04	-16.67%	Miss	4	No revisions (30d)	-16.7%
Dec 31, 2022Dec 22 Reported Mar 3, 2023Reported Mar 3	$-0.06	$-0.07	$-0.08 - $-0.04	+14.29%	Beat	6	No revisions (30d)	-20.0%
Sep 30, 2022Sep 22 Reported Nov 10, 2022Reported Nov 10	$-0.07	$-0.06	$-0.07 - $-0.05	-16.67%	Miss	8	No revisions (30d)	+0.0%
Jun 30, 2022Jun 22 Reported Aug 9, 2022Reported Aug 9	$-0.07	$-0.06	$-0.06 - $-0.06	-16.67%	Miss	0	No revisions (30d)	-40.0%
Mar 31, 2022Mar 22 Reported May 10, 2022Reported May 10	$-0.06	$-0.06	$-0.08 - $-0.04	+0.00%	Beat	6	No revisions (30d)	-200.0%
Dec 31, 2021Dec 21 Reported Mar 3, 2022Reported Mar 3	$-0.05	$-0.05	$-0.07 - $-0.03	+0.00%	Beat	6	No revisions (30d)	-150.0%
Sep 30, 2021Sep 21 Reported Nov 11, 2021Reported Nov 11	$-0.07	$-0.04	$-0.07 - $-0.02	-75.00%	Miss	3	1 0 30d	-133.3%
Jun 30, 2021Jun 21 Reported Aug 10, 2021Reported Aug 10	$-0.05	$-0.03	$-0.04 - $-0.02	-66.67%	Miss	4	No revisions (30d)	-66.7%
Mar 31, 2021Mar 21 Reported May 10, 2021Reported May 10	$-0.02	$-0.03	$-0.03 - $-0.02	+33.33%	Beat	3	No revisions (30d)	+33.3%
Dec 31, 2020Dec 20 Reported Feb 25, 2021Reported Feb 25	$-0.02	$-0.03	$-0.04 - $-0.02	+33.33%	Beat	3	No revisions (30d)	+0.0%
Sep 30, 2020Sep 20 Reported Nov 9, 2020Reported Nov 9	$-0.03	$-0.03	$-0.05 - $-0.02	+0.00%	Beat	3	No revisions (30d)	-512.2%
Jun 30, 2020Jun 20 Reported Aug 6, 2020Reported Aug 6	$-0.03	$-0.05	$-0.05 - $-0.05	+40.00%	Beat	2	No revisions (30d)	+0.0%
Mar 31, 2020Mar 20 Reported May 5, 2020Reported May 5	$-0.03	$-0.03	$-0.03 - $-0.03	+0.00%	Beat	2	No revisions (30d)	+25.0%
Dec 31, 2019Dec 19 Reported Mar 10, 2020Reported Mar 10	$-0.02	$0.00	$0.00 - $0.00	N/A	Beat	0	No revisions (30d)	+0.0%
Sep 30, 2019Sep 19 Reported Nov 14, 2019Reported Nov 14	$-0.00	N/A	-	N/A	Beat	-	-	+51.0%
Jun 30, 2019Jun 19 Reported Aug 8, 2019Reported Aug 8	$-0.03	N/A	-	N/A	Beat	-	-	-50.0%
Mar 31, 2019Mar 19 Reported May 9, 2019Reported May 9	$-0.04	N/A	-	N/A	Beat	-	-	-500.0%
Dec 31, 2018Dec 18 Reported Mar 12, 2019Reported Mar 12	$-0.02	N/A	-	N/A	Beat	-	-	+84.6%
Sep 30, 2018Sep 18 Reported Nov 12, 2018Reported Nov 12	$-0.01	N/A	-	N/A	Beat	-	-	+95.2%
Jun 30, 2018Jun 18 Reported Aug 7, 2018Reported Aug 7	$-0.02	N/A	-	N/A	Beat	-	-	-300.0%
Mar 31, 2018Mar 18 Reported May 14, 2018Reported May 14	$0.01	N/A	-	N/A	Beat	-	-	+0.0%
Dec 31, 2017Dec 17 Reported Mar 6, 2018Reported Mar 6	$-0.13	N/A	-	N/A	Beat	-	-	-155.6%
Sep 30, 2017Sep 17 Reported Nov 9, 2017Reported Nov 9	$-0.21	N/A	-	N/A	Beat	-	-	+62.5%
Jun 30, 2017Jun 17 Reported Aug 10, 2017Reported Aug 10	$0.01	N/A	-	N/A	Beat	-	-	-
Mar 31, 2017Mar 17 Reported May 8, 2017Reported May 8	$0.01	N/A	-	N/A	Beat	-	-	-
Dec 31, 2016Dec 16 Reported Mar 16, 2017Reported Mar 16	$0.23	N/A	-	N/A	Beat	-	-	-
Sep 30, 2016Sep 16 Reported Nov 7, 2016Reported Nov 7	$-0.56	N/A	-	N/A	Beat	-	-	-

Key Metrics

Valuation
P/E Ratio	-5.98	EV/EBITDA	151.44x
Price/FCF	N/A	FCF Yield	N/A
Profitability
Profit Margin	-74.20%	Operating Margin	-59.60%
ROE	-184.30%	ROIC	-100.34%
Financial Health
Debt/Equity	0.46x	Interest Coverage	52.43x
Current Ratio	1.42x	Quick Ratio	0.95x
Trading Statistics
Beta	1.40	Avg Volume	630.42K
52-Week High	$3.59	52-Week Low	$1.24

Technical Indicators Dashboard

Moving Averages

SMA 10$1.43

SMA 20$1.41

SMA 50$1.52

SMA 200$1.97

EMA 10$1.43

EMA 20$1.43

EMA 50$1.52

EMA 200$1.89

MACD

Line: -0.01Signal: -0.03Hist: 0.02

ADX

ADX: 12.2+DI: 19.1-DI: 20.5

Aroon & PSAR

Aroon Up92.0

Aroon Down16.0

PSAR$1.32

Bollinger Bands

Upper Band$1.48

Lower Band$1.35

%B Position947%(Upper)

Band Width0.77

RSI (14-Day)

Neutral

50.8

Momentum Oscillators

Stoch %K74.6

Stoch %D73.6

Williams %R-28.6

ROC (10d)4.3%

Momentum0.06

CCI (20d)85.7

MFI (14d)42.7

Volatility Measures

ATR (14d)$0.08(5.6%)

StdDev (20d)0.03

Hist Vol42.1%(High)

Volume Flow

VWAP$1.45

OBV1.5M

AD Line-9.1M

CMF (20d)-0.012

Volume Metrics

Avg Vol (20d)611.7K

Vol Ratio1.0x

VWMA (20d)$1.41

Pivot Points

R3$1.53

R2$1.51

R1$1.48

Pivot Point$1.46

S1$1.43

S2$1.41

S3$1.38

Advanced Oscillators

TSI-5.17

Ultimate Osc47.0

KST-35.05

Financial Data

Quarter	Jun 2026	Mar 2026	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024	Sep 2024	Jun 2024	Mar 2024	Dec 2023	Sep 2023
Total Revenue	$7.67M	$6.29M	$8.64M	$7.46M	$8.80M	$7.47M	$6.34M	$9.20M	$4.50M	$6.88M	$4.57M	$7.80M
Cost of Revenue	$3.18M	$2.50M	$4.32M	$3.36M	$4.22M	$3.41M	$3.12M	$5.10M	$1.19M	$2.91M	$1.83M	$3.74M
Gross Profit	$4.49M	$3.79M	$4.33M	$4.10M	$4.58M	$4.06M	$3.22M	$4.10M	$3.31M	$3.97M	$2.74M	$4.06M

Operating Expenses	$9.05M	$9.78M	$9.98M	$10.66M	$8.56M	$9.99M	$10.84M	$10.44M	$9.33M	$8.71M	$8.04M	$9.70M
R&D	$2.39M	$2.40M	$2.71M	$2.55M	$1.78M	$2.35M	$2.79M	$2.45M	$2.27M	$2.24M	$2.21M	$2.67M
SG&A	$4.07M	$4.76M	$4.17M	$5.18M	$4.00M	$4.50M	$5.14M	$4.84M	$3.76M	$3.47M	$3.04M	$3.93M
Operating Income	$-4,568,000	$-5,981,000	$-5,649,000	$-6,557,000	$-3,977,000	$-5,929,000	$-7,627,000	$-6,345,000	$-6,021,000	$-4,746,000	$-5,304,000	$-5,639,000

Interest Income	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Interest Expense	$-100,000	$-125,000	$-118,000	$-91,000	$-152,000	$-106,000	$-114,000	$-150,000	$-191,000	$-239,000	$-261,000	$-270,000
Income Before Tax	$-4,468,000	$-5,856,000	$-5,529,000	$-6,466,000	$-3,825,000	$-5,823,000	$-7,513,000	$-6,195,000	$-5,830,000	$-4,507,000	$-5,043,000	$-5,369,000
Income Tax Expense	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0

Net Income	$-4,468,000	$-5,861,000	$-5,531,000	$-6,463,000	$-3,826,000	$-5,823,000	$-7,515,000	$-6,190,000	$-5,833,000	$-4,507,000	$-5,040,000	$-5,369,000

EBITDA	$-4,161,000	$-5,586,000	$-5,254,000	$-6,168,000	$-3,576,000	$-5,559,000	$-7,264,000	$-6,015,000	$-5,885,000	$-4,606,000	$-5,166,000	$-5,492,000
EBIT	$-4,568,000	$-5,981,000	$-5,649,000	$-6,557,000	$-3,977,000	$-5,929,000	$-7,627,000	$-6,345,000	$-6,021,000	$-4,746,000	$-5,304,000	$-5,639,000

* Some calculated fields are derived from available data when not provided by source

Related GNG Research

No research available

Be the first to write about STXS

News

Citizens lowers Stereotaxis stock price target to $3 on guidance cut

Citizens has lowered its price target for Stereotaxis (NYSE:STXS) shares to $3.00 from $4.00, while maintaining a Market Outperform rating. This adjustment follows the company's Q2 2026 operating results, which showed revenue slightly below Wall Street expectations and updated full-year guidance lowered due to conservatism around system placements. Despite the stock's significant decline and current overvaluation according to InvestingPro, the firm reiterated its rating, noting traction in Stereotaxis' new robotic catheter and digital surgery products.

Investing.com Canada•Aug 27, 2026 5:04 AM8/27/26•

Bearish

STXS | Stereotaxis, Inc. Common Stock Financials - Revenue Breakdown

This article provides a detailed financial overview of Stereotaxis, Inc. (STXS), including real-time price, financial statements, insider trading activity, institutional ownership, and analyst ratings. It highlights the company's business in robotic technologies for treating arrhythmias and its revenue streams from systems, disposables, royalty, and sublease. The article also touches on various financial metrics, corporate lobbying, government contracts, and an estimated Smart Score.

Quiver Quantitative•Aug 23, 2026 6:44 PM8/23/26•

Neutral

New >5% shareholder emerges in Stereotaxis (STXS) stock

Investor Daniel Louis Kaufman has disclosed a significant 5.9% ownership stake in Stereotaxis, Inc. (STXS) common stock through a Schedule 13G filing. This ownership amounts to 5,956,714 shares, over which Kaufman holds sole voting and dispositive power. The filing indicates a passive investment, not intended to change or influence control of the company.

Stock Titan•Aug 19, 2026 9:42 PM8/19/26•

Neutral

Stereotaxis (STXS) Q2 2026 Earnings Call Transcript

Stereotaxis reported Q2 2026 results, highlighting a strategic shift towards proprietary robotic ecosystems and away from third-party catheters. The company saw a significant commercial inflection point with the U.S. launch of the MAGiC catheter and FDA clearance of the Synchrony system, leading to a 270% sequential growth in robotic catheter revenue. Despite supply constraints and procedural pressures from transitioning away from Johnson & Johnson, Stereotaxis is confident in achieving cash flow profitability by the first half of 2027, driven by increasing manufacturing output and strong demand for its new products, including its first U.S. GenesisX purchase by an academic medical center.

The Globe and Mail•Aug 18, 2026 10:40 PM8/18/26•

Bullish

Stereotaxis Number of Employees 2026 | Employee Count & Headcount Data

Stereotaxis, Inc. (STXS) has approximately 131 employees worldwide as of March 2026, representing a 14.1% decline from 153 employees in 2023, though up 0.7% year-over-year in 2026. The company, headquartered in St. Louis, Missouri, and founded in 1990, is actively hiring with 15 job postings in 2026. Its workforce is concentrated in North America (63.1%), and the average salary is $122,979.

Revelio Labs•Aug 18, 2026 12:10 PM8/18/26•

Neutral

Frequently Asked Questions About STXS

Does STXS pay dividends?: Stereotaxis Inc (STXS) does not currently pay a regular dividend.
What is STXS's market cap?: Stereotaxis Inc (STXS) has a market capitalization of $144.29M with a current stock price of $1.45.

Get full access to GNG Research

Create a free account to access portfolio tracking, advanced tools, and more.

Create Free Account Log In